Modulation of toll-like receptor 3 expression by antisense oligonucleotides
Details for Australian Patent Application No. 2009279857 (hide)
International Classifications
Event Publications
3 February 2011 PCT application entered the National Phase
PCT publication WO2010/017154 Priority application(s): WO2010/017154
6 September 2012 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Idera Pharmaceuticals, Inc., Application No. 2009279857, under INID (72) correct the co-inventor to Kandimalla, Ekambar
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009279865-Anti-hepcidin-25 selective antibodies and uses thereof
2009279855-Modulation of toll-like receptor 8 expression by antisense oligonucleotides
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser